Skip to main content
Knight Therapeutics Inc. (TSX: GUD)
Canada flag Canada · Delayed Price · Currency is CAD
5.37
+0.03 (0.56%)
Dec 3, 2024, 1:52 PM EST

Knight Therapeutics Revenue

Knight Therapeutics had revenue of 92.26M CAD in the quarter ending September 30, 2024, with 13.21% growth. This brings the company's revenue in the last twelve months to 348.64M, up 3.87% year-over-year. In the year 2023, Knight Therapeutics had annual revenue of 328.20M with 11.80% growth.

Revenue (ttm)
348.64M
Revenue Growth
+3.87%
P/S Ratio
1.56
Revenue / Employee
480.88K
Employees
725
Market Cap
538.29M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023328.20M34.64M11.80%
Dec 31, 2022293.56M50.09M20.57%
Dec 31, 2021243.48M43.96M22.03%
Dec 31, 2020199.52M152.06M320.39%
Dec 31, 201947.46M34.96M279.69%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bausch + Lomb Corporation 6.33B
Bausch Health Companies Inc. 12.80B
Curaleaf Holdings, Inc. 1.83B
dentalcorp Holdings Ltd. 1.51B
Tilray Brands, Inc. 1.10B
WELL Health Technologies Corp. 957.69M
Sienna Senior Living Inc. 867.55M
Cronos Group Inc. 150.26M
Revenue Rankings

Knight Therapeutics News

More News